Sort
46,585 grants matching “heart failure”
Anatomical Remodeling and Electrical Conduction in Heart
$397,740Johns Hopkins University · R01 · FY2003 · HL
Diagnosis and Treatment of Iron Disorders.
$397,720Jeffery Miller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
$397,693Dwight A Towler · Ut Southwestern Medical Center · R01 · FY2015 · HL
New method to treat or prevent corneal graft rejection
$397,688Qingguo Xu · Virginia Commonwealth University · R01 · FY2020 · EY
Regulation of Adenylyl Cyclase Signaling Pathways
$397,679Carmen W Dessauer · University Of Texas Hlth Sci Ctr Houston · R01 · FY2014 · GM
New method to treat or prevent corneal graft rejection
$397,659Qingguo Xu · Virginia Commonwealth University · R01 · FY2019 · EY
CHS research resources for the cardiovascular health of older adults
$397,655Bruce M Psaty · University Of Washington · U01 · FY2018 · HL
Prescribing of opioids at hospital discharge and associated adverse patient outcomes
$397,642Anupam Bapu Jena · Harvard Medical School · R01 · FY2019 · HS
CAUSE OF CARDIOVASCULAR COMPLICATIONS IN HIV INFECTION
$397,629Baylor College Of Medicine · R01 · FY2001 · HL
Hemodynamic Regulation of Thromboresistance
$397,601Jeffrey James Rade · Johns Hopkins University · R01 · FY2007 · HL
SWELL1-LRRC8 mediated regulation of skeletal muscle function and metabolism
$397,593Rajan Sah · Washington University · R01 · FY2024 · DK
Microstructural Cues for the Treatment of Heart Failure
$397,590Tejal A. Desai · University Of California, San Francisco · R01 · FY2020 · HL
Genes and Metabolism: Targeting Mitochondrial Dysfunction in Atrial Fibrillation
$397,584David R Van Wagoner · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · HL
Genes and Metabolism: Targeting Mitochondrial Dysfunction in Atrial Fibrillation
$397,584David R Van Wagoner · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · HL
Genes and Metabolism: Targeting Mitochondrial Dysfunction in Atrial Fibrillation
$397,582David R Van Wagoner · Cleveland Clinic Lerner Com-Cwru · P01 · FY2025 · HL
Targeting Novel BMPR2 modifiers in Pulmonary Hypertension with Repurposed Drugs
$397,562Edda Frauke Spiekerkoetter · Stanford University · R01 · FY2016 · HL
Skeletal muscle plasticity, fitness and health after SCI
$397,511University Of Georgia (Uga) · R01 · FY2004 · HD
Immunology of xenogeneic extracellular matrix scaffolds for heart valve tissue engineering
$397,500Leigh Gareth Griffiths · Mayo Clinic Rochester · R01 · FY2023 · HL
Clearance of macrophage p62-enriched protein aggregates as a therapy for atherosclerosis
$397,500Babak Razani · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL
Transcriptional Regulation of Angiotensinogen Gene
$397,500Ashok Kumar Kumar · New York Medical College · R01 · FY2010 · HL
The role of NF2 in myocardial ischemia and reperfusion injury
$397,500Dominic P Del Re · Rbhs-New Jersey Medical School · R01 · FY2018 · HL
Microprotein Regulation of Mitochondrial Function
$397,500Catherine A Makarewich · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
Immunology of xenogeneic extracellular matrix scaffolds for heart valve tissue engineering
$397,500Leigh Gareth Griffiths · Mayo Clinic Rochester · R01 · FY2022 · HL
Cardiorenal Fibrosis: Biology and Therapeutics
$397,500Sasantha Jeson Sangaralingham · Mayo Clinic Rochester · R01 · FY2020 · HL
Novel Peptide Therapeutics for Cardiorenal Protection in Heart Failure
$397,500John C Burnett · Mayo Clinic Rochester · R01 · FY2019 · HL